Drug Database
Back to search

Norway· NO-ID_A5D3F642-BCD7-4E4E-B99D-4CB97D004304

Glycophos

A sodium glycerophosphate product containing sodium glycerophosphate, registered in Norway by Fresenius Kabi. The same ATC class is registered in 9 of our 19 countries.

ATC B05XA14

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedGlycophosATCB05XA14REGISTER NO.NO-ID_A5D3F642-BCD7-4…PACKS LISTED3CHECKEDSeptember 25, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about sodium glycerophosphateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Sodium glycerophosphate is registered in 9 of 19 countries.

Countries holding a registration under ATC B05XA14 (sodium glycerophosphate), each read from that country’s own register.

  • This record: Norway, from FEST (Norway)
  • 6 of them publish a price we can compare per daily dose
Search sodium glycerophosphate products by name

Sodium glycerophosphate · ATC B05XA14

9 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FEST (Norway)
Active substance
Sodium Glycerophosphate
Manufacturer
Fresenius Kabi
Country
Norway (NO)
ATC code
B05XA14
ATC class
Sodium glycerophosphate
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
September 25, 2026

Packs & prices · 3

  • no_merkevare_id
    ID_A5D3F642-BCD7-4E4E-B99D-4CB97D004304
  • no_varenummer
    256399
    20 x 20
  • gtin
    4052682040719

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

2 interactions on record for sodium glycerophosphate.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check sodium glycerophosphate against other medicinesHow interaction checks work

Sodium glycerophosphate · interactions on record

2 records

  • 2 severe

Most severe, free to view

  • ErdafitinibL01EN01severe
  • ErdafitinibL01EX16severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Sodium glycerophosphate in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All sodium glycerophosphate products

Authorised across Europe · EMA

The same active substance is authorised in 20 EEA countries. Names it is sold under:

  • Austria · Glycophos
  • Belgium · Glycophos
  • Cyprus · Glycophos
  • Czechia · Sodium Glycerophosphate Fresenius
  • Germany · Natriumglycerophosphat-Ampulle Fresenius
  • Denmark · Glycophos
  • Spain · Glycophos
  • Finland · Glycophos
  • France · Glycerophosphate De Sodium
  • Greece · Glycophos
  • Hungary · Nátrium-Glicerin-Foszfát Fresenius
  • Italy · Glycophos
  • Lithuania · Glycophos
  • Latvia · Glycophos
  • Netherlands · Glycophos
  • Poland · Glycophos
  • Portugal · Glycophos
  • Romania · Glycophos
  • Sweden · Glycophos
  • Slovakia · Sodium Glycerophosphate Fresenius

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/6c4c64bd-b453-4295-9b31-e8428a25f730
GET /v1/drugs/6c4c64bd-b453-4295-9b31-e8428a25f730?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Konsentrat til infusjonsvæske, oppløsning",
  "source": "fest",
  "status": "A",
  "atc_name": "Natriumglyserofosfat",
  "merkevare_id": "ID_A5D3F642-BCD7-4E4E-B99D-4CB97D004304",
  "name_form_strength": "Glycophos kons til inf oppl 216 mg/ml",
  "prescription_group": "C"
}
API referenceMCP serverPlans

See everything about sodium glycerophosphate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console